Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.667 | 0.680 | 4 | 55126199 | upstream gene variant | A/G | snv | 0.53 |
|
0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.827 | 0.120 | 4 | 55125564 | 5 prime UTR variant | T/C | snv | 0.48 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2012 | 2016 | |||||||
|
0.827 | 0.120 | 4 | 55125564 | 5 prime UTR variant | T/C | snv | 0.48 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.120 | 4 | 55125564 | 5 prime UTR variant | T/C | snv | 0.48 |
|
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.120 | 4 | 55125564 | 5 prime UTR variant | T/C | snv | 0.48 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.827 | 0.120 | 4 | 55125564 | 5 prime UTR variant | T/C | snv | 0.48 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 4 | 55125564 | 5 prime UTR variant | T/C | snv | 0.48 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.827 | 0.120 | 4 | 55125564 | 5 prime UTR variant | T/C | snv | 0.48 |
|
Neoplasms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
4 | 55124971 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
4 | 55124971 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
4 | 55124971 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
4 | 55124971 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
4 | 55124971 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
0.882 | 0.200 | 4 | 55120071 | intron variant | T/C | snv | 0.12 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.200 | 4 | 55120071 | intron variant | T/C | snv | 0.12 |
|
Eye Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.200 | 4 | 55120071 | intron variant | T/C | snv | 0.12 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.080 | 4 | 55116585 | intron variant | C/T | snv | 0.50 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.080 | 4 | 55116585 | intron variant | C/T | snv | 0.50 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
4 | 55114928 | missense variant | C/T | snv | 1.4E-05 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
4 | 55114289 | intron variant | C/A;T | snv | 4.0E-06; 0.18 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||||
|
0.732 | 0.400 | 4 | 55113391 | missense variant | C/A;T | snv | 4.0E-06; 0.11 |
|
Cardiovascular Diseases | 0.040 | 1.000 | 4 | 2012 | 2017 | |||||||
|
0.732 | 0.400 | 4 | 55113391 | missense variant | C/A;T | snv | 4.0E-06; 0.11 |
|
Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2012 | 2019 | |||||||
|
0.732 | 0.400 | 4 | 55113391 | missense variant | C/A;T | snv | 4.0E-06; 0.11 |
|
Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2016 | 2016 | |||||||
|
0.732 | 0.400 | 4 | 55113391 | missense variant | C/A;T | snv | 4.0E-06; 0.11 |
|
0.700 | 1.000 | 2 | 2018 | 2018 | ||||||||
|
0.732 | 0.400 | 4 | 55113391 | missense variant | C/A;T | snv | 4.0E-06; 0.11 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2012 | 2016 |